Relmada Therapeutics Inc (RLMD) is near the top in its industry group according to InvestorsObserver. RLMD gets an overall rating of 51. That means it scores higher than 51 percent of stocks. Relmada Therapeutics Inc gets a 85 rank in the Drug Manufacturers - Specialty & Generic industry. Drug Manufacturers - Specialty & Generic is number 138 out of 148 industries.
What do These Ratings Mean?
Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. Investors Observer makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Relmada Therapeutics Inc Stock Today?
Relmada Therapeutics Inc (RLMD) stock is trading at $39.96 as of 2:38 PM on Monday, Sep 14, a gain of $3.72, or 10.26% from the previous closing price of $36.24. The stock has traded between $36.59 and $40.87 so far today. Volume today is 74,250 compared to average volume of 73,026.
Click Here to get the full Stock Score Report on Relmada Therapeutics Inc (RLMD) Stock.
